Atrial fibrillation progression: How sick is the atrium?
After many years of lack of interest in the atrium by clinical cardiologists, the evidence of increased morbidity and mortality in patients with atrial fibrillation (AF) relocated the atrium to a central position in cardiology more than 2 decades ago.1 First came the studies showing improved outcome...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2017 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/111785 |
| Acceso en línea: | https://hdl.handle.net/2445/111785 |
| Access Level: | acceso abierto |
| Palabra clave: | Miocardiopaties Fibril·lació auricular Arrítmia Morbiditat Myocardiopathies Atrial fibrillation Arrhythmia Morbidity |
| Sumario: | After many years of lack of interest in the atrium by clinical cardiologists, the evidence of increased morbidity and mortality in patients with atrial fibrillation (AF) relocated the atrium to a central position in cardiology more than 2 decades ago.1 First came the studies showing improved outcome with the use of anticoagulants; later, the ever-lasting controversy on rate vs rhythm control; and at present, new imaging techniques and new therapeutic tools to better define atrial remodeling and improve therapy... |
|---|